Articles
Cochlear to launch new implant in EU in June
Cochlear (ASX:COH) will this month launch the first in its Nucleus Profile line of implants - the successor to its Cl500 series - in Europe. [ + ]
World's most sensitive thermometer created
Researchers from the Institute for Photonics and Advanced Sensing have produced what is claimed to be the world's most sensitive thermometer. The new and unorthodox method uses light to measure temperature. [ + ]
Benitec treats first patient in HCV trial
Benitec Biopharma (ASX:BLT) has commenced a phase I/IIa trial of ddRNAi-based therapeutic TT-034, marking the first time the treatment candidate has been used in humans. [ + ]
Sienna reagent and cancer biomarker registered with FDA
The US FDA has registered the lead product of Melbourne-based biotech company Sienna Cancer Diagnostics - the antibody SCD-A7.
[ + ]How do Australians engage with science?
A national survey on Australians' engagement with science has found that the majority have extremely positive attitudes about science and technology, though they're not always clear about the details. [ + ]
Australia rises to the challenge of creating synthetic yeast
Australia has joined the Yeast 2.0 project, an international effort to create the world's first ever synthetic complex organism: a particular strain of yeast. [ + ]
Adopting immunity
Drs Leighton Clancy and Emily Blyth are developing and conducting clinical trials on virus-specific and tumour-specific T cells with the ultimate goal of producing an improved treatment package for bone marrow transplant patients. [ + ]
Novogen to test SBPs in prostate cancer
Novogen (ASX:NRT) has identified a number of super-benzopyran (SBP) compounds with a potent effect against prostate cancer cells in vitro, and aims to trial the lead candidate in 2015. [ + ]
Prima's US patent for CVac allowed
The US patent office has granted Prima BioMed a Notice of Allowance covering a patent application protecting cancer treatment candidate CVac. [ + ]
Phosphagenics' opioid patch eases pain in horses
All six injured thoroughbred racehorses treated with Phosphagenics' TPM/oxycodone patch during a pilot trial recovered from pain within 48 hours. [ + ]
The crop scientist
Professor Graham Farquhar speaks about a distinguished research career that spans a range of fields and interests, from the development of models for photosynthesis and water use in plants to contemplating becoming a professional dancer and advising on global change. [ + ]
Heating block systems support synthesis research
Monash University's School of Chemistry has invested in a range of Asynt DrySyn Multi heating block systems to support its groundbreaking research in photovoltaics, water splitting and nanoimaging. [ + ]
Clinuvel gets orphan status for Scenesse in HHD
Clinuvel (ASX:CUV) has received EMA orphan drug designation for Scenesse in Hailey-Hailey Disease, and has revealed it expects the agency to complete its review of the product in EPP by October. [ + ]
Heavy mouse enables hard-hitting research
Scientists from the University of Cambridge have created the world's first animal enriched with heavy but non-radioactive isotopes. The 'heavy' mouse has enabled the scientists to capture in unprecedented detail the molecular structure of natural tissue by reading the magnetism inherent in the isotopes. [ + ]
Single-cell analysis inspired by microchips
US and Korean researchers have developed a device, similar to a random-access memory (RAM) chip, which moves cells rather than electrons. The device could be scaled up to sort and store hundreds of thousands of individual living cells in a matter of minutes. [ + ]
